Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 2001 Sep;52(Suppl 1):5S–10S. doi: 10.1046/j.1365-2125.2001.0520s1005.x

Best practice in therapeutic drug monitoring

Annette S Gross 1
PMCID: PMC2014621  PMID: 11564048

Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient’s medication regime and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process—the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management—are discussed.

Keywords: therapeutic drug monitoring, therapeutic management, clinical interpretation

Full Text

The Full Text of this article is available as a PDF (76.5 KB).


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES